Alpha-1 Adrenoceptor–Angiotensin II Type 1 Receptor Cross-Talk and Its Relevance in Clinical Medicine

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cardiology in Review

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CRD.0b013e31829ce723PMID 23707993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Neurohormonal Network in the RAAS Can Bend Before Breaking

  2012cited by this paper
• Angiotensin-II type 1 receptor (AT1R) and alpha-1D adrenoceptor form a heterodimer during pregnancy-induced hypertension.

  2010cited by this paper
• Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.

  2009cited by this paper
• Influence of sympathetic and AT1‐receptor blockade on angiotensin II and adrenergic agonist‐induced renal vasoconstrictions in spontaneously hypertensive rats

  2009cited by this paper
• Alteration of messenger RNA and protein levels of cardiac alpha(1)-adrenergic receptor and angiotensin II receptor subtypes during aging in rats.

  2009cited by this paper
• Age-dependent differential crosstalk between alpha(1)-adrenergic and angiotensin receptors.

  2009cited by this paper
• Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

  2007cited by this paper
• Receptor heterodimerization: a new level of cross-talk.

  2006cited by this paper
• Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade.

  2006cited by this paper
• Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

  2004cited by this paper
• Carvedilol-induced antagonism of angiotensin II: a matter of α1-adrenoceptor blockade

  2004cited by this paper
• Vasopressor Response to Angiotensin II Infusion in Patients With Chronic Heart Failure Receiving &bgr;-Blockers

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

  2003cited by this paper
• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

  2003cited by this paper
• Angiotensin II Induces Catecholamine Release by Direct Ganglionic Excitation

  2002cited by this paper
• Literature alert

  2002cited by this paper
• The Regulation of Sympathetic Outflow in Heart Failure

  2001cited by this paper
• Vascular adrenoceptors: an update.

  2001cited by this paper
• A TRIAL OF THE BETA-BLOCKER BUCINDOLOL IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE

  2001cited by this paper
• Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan and captopril

  2001cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

  2000cited by this paper
• Beta-blocker Evaluation of Survival Trial

  2000cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• [Interaction between the sympathetic and renin-angiotensin system].

  1998cited by this paper
• Cross Talk Between Angiotensin AT1 and α1-Adrenergic Receptors : Angiotensin II Downregulates α1a-Adrenergic Receptor Subtype mRNA and Density in Neonatal Rat Cardiac Myocytes

  1997cited by this paper
• Cross talk between angiotensin AT1 and alpha 1-adrenergic receptors: angiotensin II downregulates alpha 1a-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes.

  1997cited by this paper
• ACE inhibition: postsynaptic adrenergic sympatholytic action in men.

  1997cited by this paper
• Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.

  1997cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage.

  1995cited by this paper
• Identification of alpha 1-adrenoceptor subtypes involved in the antinatriuretic response to intrarenal infusion of phenylephrine.

  1995cited by this paper
• Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells.

  1995cited by this paper
• Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes. alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts.

  1994cited by this paper
• Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D.

  1994cited by this paper
• Postjunctional regulation by angiotensin II of alpha 1-adrenoceptor-mediated pressor responses in the rat.

  1994cited by this paper
• Distribution of α1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with α1B and α1D

  1994cited by this paper
• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

  1993cited by this paper
• Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca++ influx: role of protein kinase C.

  1992cited by this paper
• Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure.

  1992cited by this paper
• Prazosin blunts the antinatriuretic effect of circulating angiotensin II in man

  1992cited by this paper
• Angiotensin II augments sympathetically mediated arteriolar constriction in man.

  1991cited by this paper
• Angiotensin II Amplification of α‐Adrenergic Vasoconstriction: Role of Receptor Reserve

  1988cited by this paper
• The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interaction.

  1987cited by this paper
• The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system.

  1987cited by this paper
• Non-steroidal anti-inflammatory agents and the gastrointestinal tract.

  1986cited by this paper
• Interaction between the adrenergic and renin-angiotensin-aldosterone-systems.

  1986cited by this paper
• Interaction between the adrenergic and renin-angiotensin-aldosterone-systems.

  1986cited by this paper
• Interaction between sympathetic and renin-angiotensin system.

  1984cited by this paper
• Effect of captopril on sympathetic neurotransmission in pithed normotensive rats.

  1983cited by this paper
• Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by α1 and α2 stimulation in pithed normotensive rats

  1982cited by this paper
• Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive rats.

  1982cited by this paper

• Pulmonary Arterial Hypertntion Causes Disregultion of Systemic Circulation via Supressesion of Baroceptor Control of the Heart Rhytm

  2024influential citation
• Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death

  2020cites this paper
• Protective effects of MCR-1329, a dual α_1 and angII receptor antagonist, in mineralocorticoid-induced hypertension

  2016cites this paper